Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer

Clicks: 350
ID: 114848
1999
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
In low-risk patients with cancer who have fever and granulocytopenia, oral therapy with ciprofloxacin plus amoxicillin-clavulanate is as effective as intravenous therapy.
Reference Key
wv1999theoral Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Kern WV;Cometta A;De Bock R;Langenaeken J;Paesmans M;Gaya H;;
Journal The New England journal of medicine
Year 1999
DOI DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/10423465
Keywords
Administration National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't adult female male adolescent aged middle aged Child Comparative Study Prospective Studies preschool 80 and over Clinical Trial Randomized Controlled Trial Multicenter Study neoplasms / drug therapy bacteremia / mortality drug therapy fever / drug therapy* survival rate agranulocytosis / drug therapy* fever / etiology amoxicillin / administration & dosage ceftriaxone / administration & dosage oral neoplasms / complications intravenous infusions combination / administration & dosage* pmid:10423465 doi:10.1056/nejm199907293410502 w v kern a cometta h gaya agranulocytosis / etiology agranulocytosis / mortality amikacin / administration & dosage antineoplastic agents / adverse effects* bacteremia / drug therapy ciprofloxacin / administration & dosage clavulanic acid / administration & dosage combination / adverse effects

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.